These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22878157)

  • 1. Impact of margin status on outcomes following accelerated partial breast irradiation using single-lumen balloon-based brachytherapy.
    Shah C; Wilkinson JB; Keisch M; Beitsch P; Arthur D; Lyden M; Vicini FA
    Brachytherapy; 2013; 12(2):91-8. PubMed ID: 22878157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial.
    Shah C; Badiyan S; Ben Wilkinson J; Vicini F; Beitsch P; Keisch M; Arthur D; Lyden M
    Ann Surg Oncol; 2013 Oct; 20(10):3279-85. PubMed ID: 23975302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial Data.
    Wilkinson JB; Beitsch PD; Shah C; Arthur D; Haffty BG; Wazer DE; Keisch M; Shaitelman SF; Lyden M; Chen PY; Vicini FA
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1179-85. PubMed ID: 23182700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
    Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).
    Vicini F; Beitsch PD; Quiet CA; Keleher AJ; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer HM; Lyden M
    Cancer; 2008 Feb; 112(4):758-66. PubMed ID: 18181095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.
    Vicini F; Shah C; Ben Wilkinson J; Keisch M; Beitsch P; Lyden M
    Ann Surg Oncol; 2013 Apr; 20(4):1275-81. PubMed ID: 23054123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of local recurrence following accelerated partial breast irradiation: a pooled analysis.
    Shah C; Wilkinson JB; Lyden M; Beitsch P; Vicini FA
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e825-30. PubMed ID: 22330996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-institution review of accelerated partial breast irradiation in patients considered "cautionary" by the American Society for Radiation Oncology.
    Stull TS; Catherine Goodwin M; Gracely EJ; Chernick MR; Carella RJ; Frazier TG; Barrio AV
    Ann Surg Oncol; 2012 Feb; 19(2):553-9. PubMed ID: 21769461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
    Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesions.
    Keisch M; Vicini F; Beitsch P; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Zannis V; Kuerer H
    Am J Surg; 2009 Oct; 198(4):505-7. PubMed ID: 19800456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
    Dunne C; Burke JP; Morrow M; Kell MR
    J Clin Oncol; 2009 Apr; 27(10):1615-20. PubMed ID: 19255332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.
    Vicini FA; Beitsch PD; Quiet CA; Keleher A; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer H; Whitacre EB; Whitworth PW; Fine RE; Haffty BG; Arrambide LS
    Cancer; 2005 Sep; 104(6):1138-48. PubMed ID: 16088962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity.
    Vargo JA; Verma V; Kim H; Kalash R; Heron DE; Johnson R; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):285-91. PubMed ID: 24268787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation.
    Wobb JL; Chen PY; Shah C; Moran MS; Shaitelman SF; Vicini FA; Mbah AK; Lyden M; Beitsch P
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):312-8. PubMed ID: 25446607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.